MUMBAI, 28 September, 2018 (GPN) : Brand ambassador Soha Ali Khan took a tour of Cocoon Fertility’s clinical and laboratory facilities in Thane. She also posed with babies conceived through assisted reproductive technologies, at Cocoon Fertility, along with its doctors Dr Anagha Karkhanis and Dr Rajalaxmi Walavalkar.
Cocoon Fertility was incepted in 2013, with the promise of a safe, truthful, ethical and empathetic experience for to-be parents. It offers a complete range of Assisted Reproductive Technology (ART) services, all under one roof. This includes In Vitro Fertilizaton (IVF), Intracytoplasmic Sperm Injection (ICSI), Embryo Freezing (Vitrification) and Frozen Embryo Transfer (FET), PICSI (Physiological Intra Cytoplasmic Sperm Injection), Intra Uterine Insemination (IUI), and male procedures like PESA/ TESA, to name a few.
Soha Ali Khan was thoroughly impressed with the range of equipment and state-of-the-art technologies available, to help couples who are denied natural parenthood. She said, “ This is my first visit to any fertility lab. I am happy to know that couples facing infertility issues have so may options today; thanks to responsible IVF centres like Cocoon Fertility. I was also happy to note that, Dr Anagha, Dr Rajalaxmi and I share a common educational background in the UK. Its a rigorous training ground and prepares you well for challenges ahead.”
Dr Rajalaxmi Walavalkar added, “ We are especially excited today. We are happy to announce the start of Pre-Implantation Genetic Services at our Thane Centre. Our lab here is now fully licensed for offering PGD / PGS services in Thane. This offers complete range of solutions for couples wanting to avoid genetic disease in their offspring and for couples who have had recurrent miscarriages and IVF failures.We are also delighted to introduce Lykos IVF laser at our centre to help in PGD-PGS.”
Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one parent or both, has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality.
Dr Anagha Karkhanis added, “ “PGD begins with the normal process of IVF that includes egg retrieval and fertilization with sperm in a laboratory. Over the next three days the embryo will divide into eight cells. First, one or two cells are removed from the embryo. The cells are then evaluated to determine if the inheritance of a problematic gene is present in the embryo.Once the PGD procedure has been performed and embryos free of genetic problems have been identified, the embryo will be placed back in the uterus, and implantation will be attempted,” explained Dr Anagha Karkhanis.”
With this new technology, women aged 35 and over, carriers of sex-linked genetic disorders, carriers of single gene disorders, those with known chromosomal disorders, women experiencing recurring pregnancy loss and women with recurrent failed fertility treatment can benefit.Ends